Patients with type 2 diabetes who use GLP-1 receptor agonists have a significantly lower risk for lung cancer than those who use DPP-4 inhibitors, according to a large retrospective cohort study.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/can-glp-1-drugs-protect-against-lung-cancer-t2d-2025a1000vab?src=rss
Author :
Publish date : 2025-11-12 02:50:00
Copyright for syndicated content belongs to the linked Source.
